A blood-based composite panel that screens Alzheimer's disease
Abstract Background Blood tests would be much easier to implement in the clinical diagnosis of Alzheimer's disease (AD) as minimally invasive measurements. Multiple inspection technologies promoted AD-associated blood biomarkers' exploration. However, there was a lack of further screening...
Saved in:
Main Authors: | Yan Wang (Author), Ying Li (Author), Yan Li (Author), Tingting Li (Author), Qi Wang (Author), Qigeng Wang (Author), Shuman Cao (Author), Fangyu Li (Author), Jianping Jia (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A circular RNA blood panel that differentiates Alzheimer's disease from other dementia types
by: Ziye Ren, et al.
Published: (2022) -
Biomarkers for the Clinical Diagnosis of Alzheimer's Disease: Metabolomics Analysis of Brain Tissue and Blood
by: Yang-Yang Wang, et al.
Published: (2021) -
Integrated analysis of genes shared between type 2 diabetes mellitus and osteoporosis
by: Fangyu Li, et al.
Published: (2024) -
The role of GZMA as a target of cysteine and biomarker in Alzheimer's disease, pelvic organ prolapse, and tumor progression
by: Yan Li, et al.
Published: (2024) -
Ultrasound Combined With Microbubbles Loading BDNF Retrovirus to Open Blood-Brain Barrier for Treatment of Alzheimer's Disease
by: Feng Wang, et al.
Published: (2021)